COMMUNIQUÉS West-GlobeNewswire

HealthEquity Announces Strong Sales, Presentation at JP Morgan Healthcare Conference

08/01/2018 - 15:05

DRAPER, Utah, Jan. 08, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") non-bank custodian, today announced significant [...]

Aptevo Therapeutics Begins Patient Dosing in Phase 2 Clinical Trial of Otlertuzumab in Peripheral T-Cell Lymphoma

08/01/2018 - 15:00

SEATTLE, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that it has commenced [...]

Alphatec Announces Preliminary Fourth Quarter and Full Year 2017 Revenue and Corporate Updates

08/01/2018 - 15:00

CARLSBAD, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC ), a provider of innovative spine surgery solutions with a mission to improve patient lives through [...]

Progyny Reports Over 100% Revenue Growth in 2017

08/01/2018 - 15:00

New York, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, today announced it has achieved over 100% revenue growth in 2017. Progyny’s innovative carve-out fertility benefits [...]

athenahealth Announces Fourth Quarter and Full Year 2017 Earnings Conference Call

08/01/2018 - 15:00

WATERTOWN, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that it will hold a [...]

Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at J.P. Morgan Healthcare Conference

08/01/2018 - 15:00

By the end of 2022, Company expects to have three experimental medicines in early-stage clinical trials and two experimental medicines in or ready for late-stage clinical trials Announces first acquisition with purchase [...]

Rexahn Pharmaceuticals to Present at Biotech Showcase™ 2018

08/01/2018 - 15:00

ROCKVILLE, Md., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, [...]

Resverlogix and Medison Pharma Ltd. Announce Strategic Licensing Agreement

08/01/2018 - 14:57

CALGARY, Alberta, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX ) today announced that it has entered into a licensing agreement with Medison Pharma Ltd. (“Medison”) for [...]

RespireRx Pharmaceuticals Inc. to Present at 10th Annual Biotech Showcase™ 2018

08/01/2018 - 14:45

CEO to Review completed Phase IIB dronabinol trial for the treatment of Obstructive Sleep Apnea (OSA) and Provide Pipeline update Glen Rock, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC QB [...]

Olainfarm will Hold Third Quarter 2017 and Latest Corporate News Investor Conference Webinar

08/01/2018 - 14:42

Olaine, 2018-01-08 14:42 CET (GLOBE NEWSWIRE) -- Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English. During the webinar Salvis Lapiņš will inform about [...]

Anthera Pharmaceuticals Announces Results of Special Meeting of Stockholders

08/01/2018 - 14:30

HAYWARD, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) is pleased to announce the results of the Special Meeting of Stockholders held on January 5, 2018. Shareholders approved [...]

Xenon Pharmaceuticals Outlines Key Milestones for 2018

08/01/2018 - 14:30

BURNABY, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today provided a corporate update and outlined its anticipated key [...]

pSivida Submits New Drug Application (NDA) for Durasert™ Three-Year Treatment for Posterior Segment Uveitis to the U.S. FDA

08/01/2018 - 14:30

WATERTOWN, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug products and technologies, today announced it has submitted its New Drug [...]

ChemoCentryx Strengthens Senior Executive Team with the Appointment of William Fairey as Executive Vice President and Chief Operating Officer

08/01/2018 - 14:30

MOUNTAIN VIEW, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, today [...]

Immunomedics and Royalty Pharma Announce Royalty Funding and Stock Purchase Agreements Totalling $250 Million

08/01/2018 - 14:30

Royalty Pharma acquires Royalty Rights on Global Net Sales of Sacituzumab Govitecan (IMMU-132) Across All Indications for $175 Million Royalty Pharma Acquires $75 Million of Immunomedics Common Stock at $17.15 per share [...]

Argos Announces $1.5 Million Equity Investment by Lummy (Hong Kong), Ltd.

08/01/2018 - 14:30

DURHAM, N.C., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]

ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial

08/01/2018 - 14:30

-------------------------------------------------------------------------------------------------- GENETIC-AF Evaluating Gencaro as Potentially First Genetically-Targeted Treatment for Atrial Fibrillation [...]

Five Prime Therapeutics Earns IND Milestone Payment Under Immune Checkpoint Pathways Discovery Collaboration with Bristol-Myers Squibb and Announces that BMS has Extended the Research Term of this Collaboration for a Second Time

08/01/2018 - 14:30

Milestone for antibody targeting TIM-3 triggers $5 million payment to Five Prime BMS extends research collaboration term for discovery, development and commercialization for therapeutics in three immune checkpoint [...]

Cerner to Release Fourth Quarter 2017 Earnings Results February 6

08/01/2018 - 14:30

KANSAS CITY, Mo., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN ) today announced it will release its fourth quarter 2017 earnings results after the market closes Tuesday, Feb. 6. Following the [...]